Mirum Pharmaceuticals, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2021. For the quarter, the company's loss from operations was $47,613,000 compared to $22,032,000 a year ago. Net Loss was $50,532,000 compared to $21,310,000 a year ago. Net loss per share, basic and diluted was $1.68 compared to $0.86 a year ago.